WO2003049744B1 - Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology - Google Patents
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatologyInfo
- Publication number
- WO2003049744B1 WO2003049744B1 PCT/US2002/038602 US0238602W WO03049744B1 WO 2003049744 B1 WO2003049744 B1 WO 2003049744B1 US 0238602 W US0238602 W US 0238602W WO 03049744 B1 WO03049744 B1 WO 03049744B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- estrogen
- administered
- consecutive days
- period
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Abstract
Claims
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200231034T SI1453521T1 (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
DK02782404.4T DK1453521T3 (en) | 2001-12-05 | 2002-12-04 | ORAL PREVENTION TO AVOID PREGNANCY AND REDUCE PREMENSTRUAL SYMPTOMATOLOGY |
ES02782404T ES2428118T3 (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and reduce premenstrual symptoms |
NZ533242A NZ533242A (en) | 2001-12-05 | 2002-12-04 | Oral extended regime contraceptive package |
HU0402651A HU230759B1 (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
MXPA04005445A MXPA04005445A (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology. |
CA2468748A CA2468748C (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
EP02782404.4A EP1453521B1 (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
BR0214716A BRPI0214716B8 (en) | 2001-12-05 | 2002-12-04 | kit, preparations, and use of estrogen and progestin in the manufacture of a drug for use in preventing pregnancy |
JP2003550793A JP2005516913A (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and reduce premenstrual symptoms |
IL16218202A IL162182A0 (en) | 2001-12-05 | 2002-12-04 | Kits containing oral contraceptives and methods utilizing the same |
AU2002348272A AU2002348272B2 (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
IL162182A IL162182A (en) | 2001-12-05 | 2004-05-27 | Kits containing oral contraceptives and methods utilizing the same |
ZA2004/04249A ZA200404249B (en) | 2001-12-05 | 2004-05-31 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
HK05108410.0A HK1076716A1 (en) | 2001-12-05 | 2005-09-23 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
IL207561A IL207561A0 (en) | 2001-12-05 | 2010-08-12 | Kits containing oral contraceptives and methods utilizing the same |
LU93156C LU93156I2 (en) | 2001-12-05 | 2016-07-20 | CONTRACEPTIVES OREUX TO AVOID PREGNANCY AND DECREASE PREMENSTRUAL SYMPTOMATOLOGY |
HUS1800033C HUS1800033I1 (en) | 2001-12-05 | 2018-07-17 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33580701P | 2001-12-05 | 2001-12-05 | |
US60/335,807 | 2001-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003049744A1 WO2003049744A1 (en) | 2003-06-19 |
WO2003049744B1 true WO2003049744B1 (en) | 2003-08-28 |
Family
ID=23313290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/038602 WO2003049744A1 (en) | 2001-12-05 | 2002-12-04 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Country Status (22)
Country | Link |
---|---|
US (5) | US7320969B2 (en) |
EP (3) | EP2305230B1 (en) |
JP (3) | JP2005516913A (en) |
CN (2) | CN100581550C (en) |
AU (2) | AU2002348272B2 (en) |
BG (1) | BG108736A (en) |
BR (1) | BRPI0214716B8 (en) |
CA (2) | CA2468748C (en) |
DK (1) | DK1453521T3 (en) |
ES (2) | ES2561491T3 (en) |
HK (2) | HK1076716A1 (en) |
HU (2) | HU230759B1 (en) |
IL (3) | IL162182A0 (en) |
LU (1) | LU93156I2 (en) |
MX (1) | MXPA04005445A (en) |
NZ (4) | NZ570295A (en) |
PL (1) | PL213122B1 (en) |
PT (1) | PT1453521E (en) |
RU (1) | RU2351339C2 (en) |
SI (1) | SI1453521T1 (en) |
WO (1) | WO2003049744A1 (en) |
ZA (1) | ZA200404249B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
PT1453521E (en) * | 2001-12-05 | 2013-10-08 | Teva Womens Health Inc | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
US7005138B2 (en) * | 2001-12-21 | 2006-02-28 | Duramed Pharmaceuticals, Inc. | Method of systematically delivering SSRIs |
US20090163454A1 (en) * | 2003-05-02 | 2009-06-25 | Duramed Pharmaceuticals, Inc. | Methods of Step-Down Hormone Treatment |
CA2524474A1 (en) * | 2003-05-02 | 2004-11-18 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
US20040222123A1 (en) * | 2003-05-06 | 2004-11-11 | Barr Laboratories, Inc. | Kit for pharmaceuticals |
WO2005007112A2 (en) * | 2003-07-16 | 2005-01-27 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US7150355B2 (en) | 2003-09-04 | 2006-12-19 | Pharmadesign Inc. | Case with pill receiving sleeves for storing and dispensing pills |
EP1535618A1 (en) | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
CA2556459C (en) | 2004-03-19 | 2013-01-15 | Warner Chilcott Company, Inc. | Extended cycle multiphasic oral contraceptive method |
US20050250746A1 (en) * | 2004-05-06 | 2005-11-10 | Matthew Iammatteo | Premenstrual dysphoric disorder medication |
WO2005117898A1 (en) * | 2004-05-26 | 2005-12-15 | Wyeth | Compositions and methods for treatment of premenstrual dysphoric disorder |
CA2581932A1 (en) * | 2004-09-27 | 2006-04-06 | Pantarhei Bioscience B.V. | A method of female contraception and a kit for use therein |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
EP2392333A1 (en) * | 2004-10-07 | 2011-12-07 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
US20060241092A1 (en) * | 2005-04-15 | 2006-10-26 | Anderson Freedolph D | Contraceptive regimens for lower-weight women |
TW200726473A (en) * | 2005-06-28 | 2007-07-16 | Wyeth Corp | Compositions and methods for treatment of cycle-related symptoms |
DE102005056527A1 (en) * | 2005-11-25 | 2007-07-12 | Grünenthal GmbH | Use of a combination of ethinylestradiol and chlormadinone acetate for the manufacture of a medicament |
DE102006003508A1 (en) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Use of hormone combination of estrogen from ethinyl estradiol and metabolites of chlormadinone acetate, with chlormadione acetate as gestagen components, for producing medicament e.g. for preventing menstruation cycle-dependent mood |
SG172654A1 (en) * | 2006-03-02 | 2011-07-28 | Warner Chilcott Co Llc | Extended cycle multiphasic oral contraceptive method |
US8399432B2 (en) * | 2009-10-27 | 2013-03-19 | Lipogen Ltd. | Compositions and methods of treatment for alleviating premenstrual syndrome symptoms |
US9517328B2 (en) | 2013-06-19 | 2016-12-13 | Kashiv Pharma, Llc | Medicament applicator |
AU2017330348B2 (en) | 2016-09-22 | 2023-09-07 | Alan B. Cash | Method to alleviate the symptoms of PMS |
US11679114B2 (en) | 2021-07-26 | 2023-06-20 | Navad Life Sciences Pte | Progestogen-only oral contraception |
Family Cites Families (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US428051A (en) * | 1890-05-13 | Wood-working machine | ||
US575690A (en) * | 1897-01-26 | Match-safe | ||
US3568828A (en) | 1967-03-01 | 1971-03-09 | Squibb & Sons Inc | Modified sequential oral contraceptive |
US4171358A (en) | 1974-04-19 | 1979-10-16 | Eli Lilly And Company | Novel contraceptive method |
US4145416A (en) | 1976-06-23 | 1979-03-20 | Schering, A.G. | Novel agents and novel methods for treatment of climacteric disturbances |
US4292315A (en) | 1977-12-30 | 1981-09-29 | Nichols Vorys | Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system |
US4215691A (en) * | 1978-10-11 | 1980-08-05 | Alza Corporation | Vaginal contraceptive system made from block copolymer |
US4291014A (en) | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4438139A (en) | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
US4390531A (en) | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
USRE35724E (en) | 1982-04-28 | 1998-02-03 | Bio-Technology General Corp. | Contraception system and method |
US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
US4826831A (en) | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US4544554A (en) | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4530839A (en) | 1983-09-26 | 1985-07-23 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4628051A (en) | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4616006A (en) | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4736849A (en) | 1983-12-19 | 1988-04-12 | Leonard Walter G | Calendar-oriented pill dispenser |
US4534468A (en) | 1983-12-19 | 1985-08-13 | Nuckols Walter S | Calendar-oriented pill dispenser |
JPS60174716A (en) | 1984-02-21 | 1985-09-09 | Yamanouchi Pharmaceut Co Ltd | Medicinal patch |
US4962098A (en) | 1987-06-15 | 1990-10-09 | Warner-Lambert Company | Graduated estrogen contraceptive |
US5010070A (en) | 1987-06-15 | 1991-04-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
US4752478A (en) | 1984-12-17 | 1988-06-21 | Merck & Co., Inc. | Transdermal system for timolol |
US5208225A (en) | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
US4762717A (en) | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
IE61236B1 (en) | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
US5108995A (en) | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
US5276022A (en) | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
US5256421A (en) | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
WO1989003692A1 (en) * | 1987-10-22 | 1989-05-05 | Massachusetts Institute Of Technology | Treating premenstrual or late luteal phase syndrome |
US4971998A (en) | 1987-10-22 | 1990-11-20 | Massachusetts Institute Of Technology | Methods for treating the premenstrual or late luteal phase syndrome |
US5043331A (en) | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
US5098714A (en) | 1989-11-16 | 1992-03-24 | Alza Corporation | Osmotic, oral dosage form for fertility control |
WO1992007824A1 (en) * | 1990-10-25 | 1992-05-14 | Schering Corporation | Process for preparing florfenicol, its analogs and oxazoline intermediates thereto |
IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
DE4104385C1 (en) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich | |
US5211952A (en) | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
ZA924811B (en) | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
MX9301121A (en) * | 1992-03-02 | 1993-09-01 | Schering Ag | METHOD AND EQUIPMENT FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRUATION WITH ESTROGEN / PROGESTIN / ANIPROGESTIN. |
DE4224534A1 (en) | 1992-07-24 | 1994-01-27 | Marika Dr Med Ehrlich | Anti-ovulation agent for hormonal contraception |
NL9301562A (en) | 1993-09-09 | 1995-04-03 | Saturnus Ag | Substitution therapy preparation. |
DE4344462C2 (en) | 1993-12-22 | 1996-02-01 | Schering Ag | Composition for contraception |
DE4344405C2 (en) * | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Anti-ovulation agent and method for hormonal contraception |
DE4411585A1 (en) | 1994-03-30 | 1995-10-05 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
US5552394A (en) | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
DE4429374C1 (en) | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component |
DE19513662A1 (en) | 1995-04-08 | 1996-10-10 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
DE19525017A1 (en) | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmaceutical combination preparation, kit and method for hormonal contraception |
FR2737411B1 (en) | 1995-08-01 | 1997-10-17 | Theramex | NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES |
DE19531936A1 (en) | 1995-08-17 | 1997-02-20 | Schering Ag | Combination preparation for contraception, containing kits and a method using them |
DE19540253C2 (en) | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Multi-phase preparation for contraception based on natural estrogens |
US5747480A (en) | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
US6139873A (en) | 1996-07-10 | 2000-10-31 | Cedars-Sinai Medical Center | Combined pharmaceutical estrogen-androgen-progestin |
AU3961697A (en) * | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
AU3888597A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
AU3888697A (en) * | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
DE19705229C2 (en) | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands |
EP0968188A1 (en) * | 1997-03-20 | 2000-01-05 | Basf Aktiengesellschaft | Substituted 2-benz(o)ylpyridines, their preparation and their use as herbicides |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
US6251956B1 (en) | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
DE19739916C2 (en) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands |
EP1011681A1 (en) | 1997-09-12 | 2000-06-28 | American Home Products Corporation | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin |
US6306914B1 (en) | 1997-10-21 | 2001-10-23 | Columbia Laboratories, Inc. | Progestin therapy for maintaining amenorrhea |
US6265393B1 (en) | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
US6214815B1 (en) | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
US6787531B1 (en) | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
US20020132801A1 (en) | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
US20010044431A1 (en) | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
CA2414938A1 (en) * | 2000-07-06 | 2002-01-17 | Simon Nicholas Jenkins | Combinations of ssri and estrogenic agents |
EP1390038A2 (en) | 2001-05-16 | 2004-02-25 | Endeavor Pharmaceuticals | Treatment of conditions relating to hormone deficiencies by administration of progestins |
US20030018018A1 (en) | 2001-07-10 | 2003-01-23 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea |
PT1453521E (en) | 2001-12-05 | 2013-10-08 | Teva Womens Health Inc | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
ES2197801B1 (en) * | 2002-03-05 | 2005-03-16 | Ferrer Internacional,S.A | PROCEDURE FOR OBTAINING THE 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-IL) PIPERIDIN-1-IL) -ETIL) -2-METHYL-6,7,8,9- TETRAHIDRO-4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONA. |
WO2003077924A1 (en) | 2002-03-11 | 2003-09-25 | Janssen Pharmaceutica N.V. | Continuous sulfatase inhibiting progestogen hormone replacement therapy |
US20030219471A1 (en) | 2002-03-11 | 2003-11-27 | Caubel Patrick Michel | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens |
US20040142914A1 (en) | 2002-03-11 | 2004-07-22 | Friedman Andrew Joseph | Extended transdermal contraceptive regimens |
US20030216366A1 (en) | 2002-04-03 | 2003-11-20 | Leonard Thomas W. | Step-down estrogen therapy |
CA2524474A1 (en) | 2003-05-02 | 2004-11-18 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
US20040251301A1 (en) | 2003-05-05 | 2004-12-16 | Niemann Amy C. | Device for calculating anticipated days for menstruation |
US20040222123A1 (en) | 2003-05-06 | 2004-11-11 | Barr Laboratories, Inc. | Kit for pharmaceuticals |
WO2005007112A2 (en) * | 2003-07-16 | 2005-01-27 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US7150355B2 (en) | 2003-09-04 | 2006-12-19 | Pharmadesign Inc. | Case with pill receiving sleeves for storing and dispensing pills |
CA2540697A1 (en) | 2003-10-01 | 2005-04-14 | Janssen Pharmaceutica N.V. | Extended triphasic contraceptive regimens |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
EP2392333A1 (en) | 2004-10-07 | 2011-12-07 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
EP1983999A4 (en) * | 2006-01-27 | 2010-10-20 | Teva Womens Health Inc | Regimens for treatment of conditions related to estrogen deficiency |
-
2002
- 2002-12-04 PT PT2782404T patent/PT1453521E/en unknown
- 2002-12-04 EP EP10181464.8A patent/EP2305230B1/en not_active Expired - Lifetime
- 2002-12-04 NZ NZ570295A patent/NZ570295A/en not_active IP Right Cessation
- 2002-12-04 ES ES10181464.8T patent/ES2561491T3/en not_active Expired - Lifetime
- 2002-12-04 CN CN02824100A patent/CN100581550C/en not_active Expired - Fee Related
- 2002-12-04 HU HU0402651A patent/HU230759B1/en not_active IP Right Cessation
- 2002-12-04 NZ NZ533242A patent/NZ533242A/en not_active IP Right Cessation
- 2002-12-04 RU RU2004121155/15A patent/RU2351339C2/en not_active IP Right Cessation
- 2002-12-04 PL PL370135A patent/PL213122B1/en unknown
- 2002-12-04 CA CA2468748A patent/CA2468748C/en not_active Expired - Lifetime
- 2002-12-04 SI SI200231034T patent/SI1453521T1/en unknown
- 2002-12-04 MX MXPA04005445A patent/MXPA04005445A/en active IP Right Grant
- 2002-12-04 JP JP2003550793A patent/JP2005516913A/en active Pending
- 2002-12-04 NZ NZ555299A patent/NZ555299A/en not_active IP Right Cessation
- 2002-12-04 CA CA2655959A patent/CA2655959C/en not_active Expired - Lifetime
- 2002-12-04 IL IL16218202A patent/IL162182A0/en unknown
- 2002-12-04 WO PCT/US2002/038602 patent/WO2003049744A1/en active Application Filing
- 2002-12-04 US US10/309,313 patent/US7320969B2/en not_active Expired - Lifetime
- 2002-12-04 EP EP02782404.4A patent/EP1453521B1/en not_active Revoked
- 2002-12-04 CN CN200910253109A patent/CN101757628A/en active Pending
- 2002-12-04 EP EP10181459A patent/EP2305229A1/en not_active Withdrawn
- 2002-12-04 DK DK02782404.4T patent/DK1453521T3/en active
- 2002-12-04 NZ NZ591627A patent/NZ591627A/en not_active IP Right Cessation
- 2002-12-04 AU AU2002348272A patent/AU2002348272B2/en not_active Expired
- 2002-12-04 BR BR0214716A patent/BRPI0214716B8/en not_active IP Right Cessation
- 2002-12-04 ES ES02782404T patent/ES2428118T3/en not_active Expired - Lifetime
-
2004
- 2004-05-27 IL IL162182A patent/IL162182A/en not_active IP Right Cessation
- 2004-05-27 BG BG108736A patent/BG108736A/en unknown
- 2004-05-31 ZA ZA2004/04249A patent/ZA200404249B/en unknown
-
2005
- 2005-09-23 HK HK05108410.0A patent/HK1076716A1/en not_active IP Right Cessation
-
2007
- 2007-08-17 US US11/892,014 patent/US7615545B2/en not_active Expired - Fee Related
- 2007-12-06 US US11/951,492 patent/US7858605B2/en not_active Expired - Fee Related
-
2008
- 2008-10-30 AU AU2008237614A patent/AU2008237614B2/en not_active Ceased
-
2010
- 2010-04-07 JP JP2010089063A patent/JP2010180236A/en not_active Withdrawn
- 2010-05-24 US US12/786,283 patent/US8338396B2/en not_active Expired - Fee Related
- 2010-08-12 IL IL207561A patent/IL207561A0/en not_active IP Right Cessation
-
2011
- 2011-08-16 HK HK11108571.7A patent/HK1154485A1/en not_active IP Right Cessation
-
2012
- 2012-02-24 JP JP2012038404A patent/JP2012107052A/en active Pending
- 2012-08-30 US US13/600,050 patent/US8680084B2/en not_active Expired - Fee Related
-
2016
- 2016-07-20 LU LU93156C patent/LU93156I2/en unknown
-
2018
- 2018-07-17 HU HUS1800033C patent/HUS1800033I1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003049744B1 (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
JP2005516913A5 (en) | ||
KR100187316B1 (en) | Low Estrogen Oral Contraceptives | |
KR100385663B1 (en) | Compounds with Progesterone-Antagonistic and Anti-Oestrogen Properties Intended for Combined Use in Female Contraception | |
AU2005294269B2 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
Benagiano et al. | Contraception today | |
HRP20070188B1 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
ATE239483T1 (en) | PHARMACEUTICAL COMBINATION PREPARATION, KIT AND METHOD FOR HORMONAL CONTRACEPTION | |
KR960706344A (en) | MEANS AND METHOD FOR HORMONAL CONTRACEPTION AND / OR THE TREATMENT OF ACNE | |
JP2010508275A (en) | Method of hormonal treatment utilizing dose escalation long-term cycle therapy program | |
RU95118436A (en) | HORMONAL SUBSTITUTION THERAPY | |
KR20060126671A (en) | Extended use combination comprising estrogens and progestins | |
AR049112A1 (en) | COMPOSITIONS, METHODS AND KIT, FOR THE TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER | |
JP2006525358A5 (en) | ||
HUP9904344A2 (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
ATE240735T1 (en) | PHARMACEUTICAL COMBINATION PREPARATION FOR HORMONAL CONTRACEPTION | |
NO314437B1 (en) | Use of at least ± n competitive progesterone antagonist for the manufacture of a drug for need-oriented, female fertility control | |
Koetsawang | Once-a-month injectable contraceptives: efficacy and reasons for discontinuation | |
HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
DE69724796D1 (en) | BIPHASIC ORAL PREVENTION METHOD AND KIT CONTAINING A COMBINATION OF PROGESTINE AND AN ESTROGEN | |
RU2225714C2 (en) | New kit of contraceptives | |
EP1468690B1 (en) | Use of estrogens for the treatment of infertility in male mammals | |
JPH08510992A (en) | Fertilization prevention and prevention methods | |
Khosla et al. | A Review on Birth control: Natural source as Anti-fertility agents | |
EA007840B1 (en) | Mesoprogestins (progesterone receptor modulator) as a component of compositions for hormone replacement therapy (hrt) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
B | Later publication of amended claims |
Free format text: 20030604 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 10873602 Country of ref document: BG Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 162182 Country of ref document: IL Ref document number: 108736 Country of ref document: BG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002348272 Country of ref document: AU Ref document number: 2468748 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004/04249 Country of ref document: ZA Ref document number: 533242 Country of ref document: NZ Ref document number: 200404249 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 750/KOLNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/005445 Country of ref document: MX Ref document number: 20028241002 Country of ref document: CN Ref document number: 1020047008683 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003550793 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004121155 Country of ref document: RU Ref document number: 2002782404 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002782404 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 207561 Country of ref document: IL |